BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26281251)

  • 1. [Interleukin-23 strengthens the anti-apoptotic and drug resistance of human tongue squamous cell carcinoma through the Wingless-related integration site/β-catenin pathway].
    Yan Q; Su Y; Zhou Y; Zhu H; Yang X; Xu J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Jun; 33(3):249-54. PubMed ID: 26281251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells.
    Li S; Jiao J; Lu Z; Zhang M
    Oncol Rep; 2009 May; 21(5):1223-33. PubMed ID: 19360298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
    Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
    Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.
    Chen S; Li H; Zhuang S; Zhang J; Gao F; Wang X; Chen W; Song M
    J Exp Clin Cancer Res; 2016 Jul; 35(1):123. PubMed ID: 27473117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The downregulation of ANGPTL4 inhibits the migration and proliferation of tongue squamous cell carcinoma.
    Huang Z; Xie J; Lin S; Li S; Huang Z; Wang Y; Ye J
    Arch Oral Biol; 2016 Nov; 71():144-149. PubMed ID: 27505034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma.
    Zhang B; Liu M; Tang HK; Ma HB; Wang C; Chen X; Huang HZ
    J Oral Pathol Med; 2012 Feb; 41(2):141-8. PubMed ID: 21793937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-xL overexpression and its association with the progress of tongue carcinoma.
    Zhang K; Jiao K; Xing Z; Zhang L; Yang J; Xie X; Yang L
    Int J Clin Exp Pathol; 2014; 7(11):7360-77. PubMed ID: 25550772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma.
    Li HF; Liu YQ; Shen ZJ; Gan XF; Han JJ; Liu YY; Li HG; Huang ZQ
    Oncol Rep; 2015 Feb; 33(2):651-60. PubMed ID: 25421538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALAT1 induces tongue cancer cells' EMT and inhibits apoptosis through Wnt/β-catenin signaling pathway.
    Liang J; Liang L; Ouyang K; Li Z; Yi X
    J Oral Pathol Med; 2017 Feb; 46(2):98-105. PubMed ID: 27353727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro gene silencing by siRNA of cyclin D1 on tongue squamous cell carcinoma cell line resistant to cisplatin].
    Zhou XJ; Zhang ZY; Zhang P; Pan HY; Chen WT; Ye DX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Nov; 41(11):646-9. PubMed ID: 17331354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
    Wang Q; Wang X; Tian X; Tang R; Xu X
    J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of E-cadherin and beta-catenin in oral squamous cell carcinomas of tongue: correlation with the clinicopathologic features and patient prognosis].
    Zhu R; Jiang XY; Song XL; Zhang W; Chen S; Liu LK
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 May; 45(5):295-8. PubMed ID: 20654247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
    Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
    Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
    Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
    Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.
    Li L; Liu HC; Wang C; Liu X; Hu FC; Xie N; Lü L; Chen X; Huang HZ
    Biomed Res Int; 2016; 2016():5378567. PubMed ID: 27529071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-24 induces cisplatin resistance by targeting PTEN in human tongue squamous cell carcinoma.
    Zheng X; Li J; Peng C; Zhao J; Chi J; Meng X; Yun X; Li D; Yu Y; Gao M; Li Y
    Oral Oncol; 2015 Nov; 51(11):998-1003. PubMed ID: 26365986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.